Welcome to BioRN

About 80 companies from the field of red biotechnology develop drugs, technology platforms and diagnostics at the Biotech Cluster Rhine-Neckar (BioRN). Globally acting healthcare companies as well as internationally renowned research institutes also play a significant  part in this development.

With its focus on personalized medicine and cancer research the BioRN cluster occupies a leading position in Germany. In 2008 it was awarded the leading-edge cluster for “Cell based and molecular medicine in the Rhine-Neckar Metropolitan Region”

News

May 16, 2012
GlaxoSmithKline to fully acquire Cellzome for £61 million
» [more]

May 16, 2012
Merck Announces Details of Merck Serono Efficiency Program and Introduces Merck Group Mid-Term Financial Targets
» [more]

May 16, 2012
Q1/2012: Merck Total Revenues Increase 3.2% to € 2.6 Billion
» [more]

Database BioRN Guide

Life Science Companies and Research Organizations

Events